ACCREA Signs Collaboration Agreement with SDS Optic S.A.

September 12, 2025

ACCREA Medical Robotics Sp. z o.o., a leader in advanced medical robotics, has signed a collaboration agreement with SDS Optic S.A. on September 12, 2025. The partnership focuses on developing a Proof of Concept for a new medical device that integrates robotic biopsy technology with real-time molecular diagnostics.

The project will combine Accrea’s robotic arm systems, designed for precise surgical and biopsy procedures, with SDS Optic’s inPROBE® microprobe. Together, the technologies aim to enable accurate tissue sampling and simultaneous molecular analysis both in vivo (inside the body) and in vitro (outside the body). A one-time animal model experiment will initiate the collaboration, testing the feasibility of this innovative approach.

ACCREA Medical Robotics specializes in robotics and control systems, with experience in international projects and a portfolio that includes robotic arms used in minimally invasive medicine. Its solutions are based on cutting-edge mechatronic technologies and software tailored to medical applications.

“Diagnosing hard-to-reach lesions in the human body is one of the greatest challenges of modern medicine. Our robotic arm solution, combined with SDS Optic’s inPROBE® technology, may create a globally unique innovation. Precise navigation to targeted areas – supported by 3D and AR visualization and real-time molecular results – can significantly improve patient safety, shorten time to diagnosis, and streamline the diagnostic pathway,” said Bartłomiej Stańczyk, CEO of ACCREA Medical Robotics.

This collaboration marks a significant step toward advancing robotics in medical diagnostics, strengthening ACCREA’s mission to support healthcare professionals with technologies that improve outcomes and enhance patient care.

Additional information about partners

ACCREA MEDICAL ROBOTICS Sp. z o.o. is a company specializing in robotics and control systems, with extensive experience in both domestic and international projects. The company offers a broad portfolio of medical robotic systems based on advanced mechatronic technologies and software. Its flagship projects include robotic arms used in surgical and biopsy procedures.

SDS Optic S.A. (NewConnect: SDS) is an innovative biotechnology company developing a breakthrough diagnostic technology that combines molecular biology, immunochemistry, medicine, and photonics. The company’s flagship solution is the inPROBE^® platform – a micrometric fiber-optic biosensor designed to enable the detection of cancer biomarkers, such as HER2, as well as other molecules directly in patient tissue. SDS Optic has initiated research on the use of inPROBE^® technology during breast cancer biopsies and in combination with endoscopic techniques for gastric cancer. Studies conducted to date have confirmed the potential of the inPROBE^®microsensor in detecting the HER2 biomarker in both in-vivo and in-vitro procedures.